https://www.selleckchem.com/pr....oducts/5-n-ethyl-n-i
th joint damage and anti-RNP in SLE. Hydroxychloroquine was a protector. Glucose-6-phosphate dehydrogenase deficiency (G6PD) is linked to hemolytic anemia with certain medications and is the most common enzyme deficiency worldwide. Although the American College of Rheumatology does not recommend routine testing for G6PD prior to initiation of hydroxychloroquine (HCQ), the package insert for HCQ does recommend careful use in patients with G6PD deficiency. We identified eligible subjects seen at our tertiary c
Like
Comment
Share
